INMD

INTEGRAMED AMERICA INC

INMD

Overview Fund Activity

Delisted

INMD was delisted on the 20th of September, 2012.

Back to rankings

Financial journalist opinion

InMode to Present at Baird 2025 Global Healthcare Conference

YOKNEAM, Israel , Sept. 2, 2025 /PRNewswire/ -- InMode Ltd.

InMode to Present at Baird 2025 Global Healthcare Conference

InMode to Participate in Upcoming Investor Conferences

YOKNEAM, Israel , Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in August: 10th Annual Needham Virtual MedTech & Diagnostics Conference Presenters: Moshe Mizrahy, Chief Executive Officer Format: Virtual one-on-one meetings When: Monday, Aug. 11 Canaccord 45th Annual Global Growth Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings When: Tuesday, Aug. 12 at 2:30 pm ET A live webcast of the presentation can be accessed here.

InMode to Participate in Upcoming Investor Conferences

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

InMode Ltd. (NASDAQ:INMD ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Danielle Joy Antalffy - UBS Investment Bank, Research Division Jeffrey D.

InMode Ltd. (INMD) Q2 2025 Earnings Call Transcript

Zacks Investment Research

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

InMode (INMD) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.34 per share a year ago.

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2025.

InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins

Zacks Investment Research

InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

InMode: Margin Pressure, But Optionality Makes It Worth A Look

InMode's fundamentals remain strong despite guidance cuts, macro headwinds, and governance disputes, making current negative sentiment appear overdone. Valuation is compelling at just 9.3x forward EPS and ~6% FCF yield, with a robust cash buffer and capital-light business model offering downside protection. Share buybacks are accelerating, shrinking share count and compounding per-share value, even if revenues remain flat, providing a powerful catalyst for upside.

InMode: Margin Pressure, But Optionality Makes It Worth A Look

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

Conference call to be held on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, July 10, 2025 /PRNewswire/ -- InMode Ltd.

InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

YOKNEAM, Israel , May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public letter dated May 9, 2025.

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

Believes the Board Should Immediately Resume and Accelerate Buybacks Asserts Board Should Remove Moshe Mizrahy as CEO of the Company MIAMI , May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to continue its stock repurchase program and to replace its CEO.

DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program

See News Rankings

Charts implemented using Lightweight Charts™